NVS has been in the news 316% more than usual

NVS has been in the news recently: Genentech, a subsidiary of Novartis AG, has received FDA approval for Susvimo, which provides sustained vision improvements for diabetic macular edema with fewer treatments than standard methods. Additionally, Novartis has partnered with Dawn Health to launch the Cora BC app, designed to assist breast cancer patients with personalized resources throughout their treatment.